Pharmacokinetic (PK) assessment of BT1718: A phase I/II a study of BT1718, a first in class bicycle toxin conjugate (BTC), in patients (pts) with advanced solid tumours

N. Cook; U. Banerji; J. Evans; A. Biondo; T. Germetaki; M. Randhawa; L. Godfrey; S. Leslie; P. Jeffrey; M. Rigby; G. Bennett; S. Blakemore; M. Koehler; A. Niewiarowski; M. Pittman; S.N. Symeonides

doi:10.1093/annonc/mdz244.026

Pharmacokinetic (PK) assessment of BT1718: A phase I/II a study of BT1718, a first in class bicycle toxin conjugate (BTC), in patients (pts) with advanced solid tumours

N. Cook
, U. Banerji
, J. Evans
, A. Biondo
, T. Germetaki
, M. Randhawa
, L. Godfrey
, S. Leslie
, P. Jeffrey
, M. Rigby
, G. Bennett
, S. Blakemore
, M. Koehler
, A. Niewiarowski
, M. Pittman
, S.N. Symeonides

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	v174
Journal	Annals of Oncology
Volume	30
DOIs	https://doi.org/10.1093/annonc/mdz244.026
Publication status	Published - Oct 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

Access to Document

10.1093/annonc/mdz244.026

Cite this

Cook, N., Banerji, U., Evans, J., Biondo, A., Germetaki, T., Randhawa, M., Godfrey, L., Leslie, S., Jeffrey, P., Rigby, M., Bennett, G., Blakemore, S., Koehler, M., Niewiarowski, A., Pittman, M., & Symeonides, S. N. (2019). Pharmacokinetic (PK) assessment of BT1718: A phase I/II a study of BT1718, a first in class bicycle toxin conjugate (BTC), in patients (pts) with advanced solid tumours. Annals of Oncology, 30, v174. https://doi.org/10.1093/annonc/mdz244.026

@article{739ae5f68d5c4ea094ae358d1f19b5c8,

title = "Pharmacokinetic (PK) assessment of BT1718: A phase I/II a study of BT1718, a first in class bicycle toxin conjugate (BTC), in patients (pts) with advanced solid tumours",

author = "N. Cook and U. Banerji and J. Evans and A. Biondo and T. Germetaki and M. Randhawa and L. Godfrey and S. Leslie and P. Jeffrey and M. Rigby and G. Bennett and S. Blakemore and M. Koehler and A. Niewiarowski and M. Pittman and S.N. Symeonides",

year = "2019",

month = oct,

doi = "10.1093/annonc/mdz244.026",

language = "English",

volume = "30",

pages = "v174",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier BV",

}

Cook, N, Banerji, U, Evans, J, Biondo, A, Germetaki, T, Randhawa, M, Godfrey, L, Leslie, S, Jeffrey, P, Rigby, M, Bennett, G, Blakemore, S, Koehler, M, Niewiarowski, A, Pittman, M & Symeonides, SN 2019, 'Pharmacokinetic (PK) assessment of BT1718: A phase I/II a study of BT1718, a first in class bicycle toxin conjugate (BTC), in patients (pts) with advanced solid tumours', Annals of Oncology, vol. 30, pp. v174. https://doi.org/10.1093/annonc/mdz244.026

TY - JOUR

T1 - Pharmacokinetic (PK) assessment of BT1718: A phase I/II a study of BT1718, a first in class bicycle toxin conjugate (BTC), in patients (pts) with advanced solid tumours

AU - Cook, N.

AU - Banerji, U.

AU - Evans, J.

AU - Biondo, A.

AU - Germetaki, T.

AU - Randhawa, M.

AU - Godfrey, L.

AU - Leslie, S.

AU - Jeffrey, P.

AU - Rigby, M.

AU - Bennett, G.

AU - Blakemore, S.

AU - Koehler, M.

AU - Niewiarowski, A.

AU - Pittman, M.

AU - Symeonides, S.N.

PY - 2019/10

Y1 - 2019/10

U2 - 10.1093/annonc/mdz244.026

DO - 10.1093/annonc/mdz244.026

M3 - Meeting Abstract

SN - 0923-7534

VL - 30

SP - v174

JO - Annals of Oncology

JF - Annals of Oncology

ER -